IHS Chemical Week

EnviroTech :: Biotech

DSM Biologics to Acquire Rhobust Technology from Danish Firm

10:33 PM MDT | May 4, 2010 | Deepti Ramesh

DSM Biologics says it has reached an agreement with biotech company Upfront Chromatography (Copenhagen, Denmark) for the acquisition of the assets and associated business of Rhobust technology for pharmaceutical and other applications. Financial details of the deal were not disclosed. DSM Biologics will gain all rights for the commercialization of Rhobust technology in various fields including the pharmaceutical industry, through the acquisition. “The acquisition of the Rhobust technology is an important addition to the portfolio of DSM Biologics,”...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa